Chemotherapy-induced neutropenia is a common side effect of cancer treatment where the patient's neutrophil count drops, increasing the risk of infections. Managing this condition often involves dose adjustments, prophylactic antibiotics, and the use of growth factors like G-CSF to stimulate neutrophil production.